Literature DB >> 2807837

Role of MRI in the diagnosis of Mills syndrome.

G Dalla Volta1, M Magoni, D Vangi, L A Vignolo.   

Abstract

We report the case of a 69 year old man who presented hemiplegia with an ascending spread suspected to be a primary form of Mills syndrome. The patient underwent MRI, which showed multiple lacunar infarcts of the periventricular and subcortical white matter. We recommend that patients with a suspected primary form of Mills syndrome should be studied with MRI.

Entities:  

Mesh：

Year:  1989        PMID： 2807837     DOI： 10.1007/bf02333948

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


  3 in total

1.  [Two cases of pyramidal syndrome, slowly progressive and secondarily bilateralized; Mills' syndrome?].

Authors:  P COSSA; P MARTIN
Journal:  Rev Neurol (Paris)       Date:  1951       Impact factor: 2.607

2.  Primary lateral sclerosis: a case report.

Authors:  M F Beal; E P Richardson
Journal:  Arch Neurol       Date:  1981-10

3.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.

Authors:  C Confavreux; G Aimard; M Devic
Journal:  Brain       Date:  1980-06       Impact factor: 13.501
  3 in total
  4 in total

1.  Giant congenital nevus and chronic progressive ascending hemiparesis (Mills syndrome). Report of a case.

Authors:  G B Frisoni; R Gasparotti; V Di Monda
Journal:  Ital J Neurol Sci       Date:  1992-04

2.  Chronic spastic atrophic hemiparesis with benign course.

Authors:  M Casmiro; M Sintini; P Martinelli; M Leonardi; R D'Alessandro
Journal:  Ital J Neurol Sci       Date:  1992-10

3.  Mills' syndrome: case report.

Authors:  Fábio Henrique de Gobbi Porto; Marco Orsini; Marco Antônio Araújo Leite; José Moreira Dos Santos; Soraia Pulier; Mariana Mello; Osvaldo J M Nascimento
Journal:  Neurol Int       Date:  2009-11-16

Review 4.  Mills' syndrome revisited.

Authors:  Stephan R Jaiser; Dipayan Mitra; Timothy L Williams; Mark R Baker
Journal:  J Neurol       Date:  2019-01-10       Impact factor: 4.849
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.